HONG KONG (Reuters) – Chinese state-owned Sinopharm plans to inject 30 billion yuan ($4.6 billion) in assets into unit Beijing Tiantan Biological Products Corp Ltd
Read more
Home ยป
HONG KONG (Reuters) – Chinese state-owned Sinopharm plans to inject 30 billion yuan ($4.6 billion) in assets into unit Beijing Tiantan Biological Products Corp Ltd
Read moreDisruptions in the circadian rhythms in lung cells may explain why adults who survived premature birth are often more at risk of severe influenza infections,
Read more